Chelsea Pinnix, MD, PhD

Chelsea Pinnix is a Professor in the Department of Radiation Oncology at MDACC where she specializes in the treatment of patients with hematologic malignancies. She graduated from the University of Pennsylvania School of Medicine in 2007, where she earned a medical degree and a PhD in Cell and Molecular Biology. She then completed residency MDACC in the Department of Radiation Oncology. In 2012 she joined MD Anderson as faculty on the Hematologic Malignancies section. Her research is focused on the maximization of the therapeutic ratio for patients with hematologic malignancies through the utilization of radiation therapy. She is the principal investigator of clinical studies aimed at decreasing normal tissue toxicity from radiation through the use of advanced technology to reduce radiation exposure, utilization of smaller field sizes or reduced RT doses. She is also focused on the identification of improved treatment strategies that incorporate radiation combined with immune based therapies in the management of aggressive and refractory lymphomas. She is presently the Director of the Radiation Oncology Residency Program at MDACC and the Vice-Chair of the MDACC Graduate Medical Education Committee. She is a board examiner for the ABR. She is the Co-PI of the MDACC NCTN LAPS UG1 grant. She currently acts as the Education Council Chair on the Board of Directors for ASTRO, she serves as the Radiation Oncology Chair on the SWOG Myeloma committee, the Radiation Oncology Representative on the NCI Lymphoma Steering Committee and is the co-chair of the NRG Hematologic Malignancies Core Working Group.

Disclosures:

• Employment: MD Anderson Cancer Center:Associate Professor:Employee
• Compensation: Merck: Grant Research Funding-End Date: present ;Lancet Haematology: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Uncompensated-End Date: present
• Ownership: none
• Leadership: Society of Immunotherapy of Cancer:DEI Task Force;National Cancer Institute Lymphoma Steering Committee:NRG Representative on the committee;SWOG:Radiation Oncology Chair;NRG Hematologic Malignancies Core Working Group:Co-Chair;International Lymphoma Radiation Oncology Group:Steering Committee Member